Delcath Systems Announces Board and Officer Changes
Ticker: DCTH · Form: 8-K · Filed: Mar 19, 2024 · CIK: 872912
Sentiment: neutral
Topics: management-change, board-of-directors, executive-appointments
TL;DR
Delcath Systems shakes up its board and exec team, filing 8-K with details.
AI Summary
On March 18, 2024, Delcath Systems, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes the election of new directors and the appointment of certain officers, alongside information regarding compensatory arrangements for these individuals. The report also covers Regulation FD disclosures and financial statements.
Why It Matters
Changes in a company's leadership and board can signal shifts in strategy, operational focus, or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive and board composition can introduce uncertainty about future strategy and execution, warranting closer investor scrutiny.
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Registrant
- March 18, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors and appointment of certain officers, but specific names and the exact number of changes are not detailed in the provided excerpt.
Are there details on new compensatory arrangements for the officers?
Yes, the filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, suggesting details are included.
What is the significance of the Regulation FD Disclosure item?
This indicates that the company is making public disclosures to ensure broad dissemination of material information, preventing selective disclosure to certain parties.
When was this 8-K report filed?
The report was filed on March 19, 2024, with the earliest event reported being March 18, 2024.
What is Delcath Systems' primary business sector?
Delcath Systems, Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' sector, with SIC code 3841.
Filing Stats: 968 words · 4 min read · ~3 pages · Grade level 10.5 · Accepted 2024-03-19 08:00:34
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value DCTH The Nasdaq Capital M
- $425,000 — k will receive an annual base salary of $425,000, pro-rated for 2024, a bonus of up to 4
Filing Documents
- d748780d8k.htm (8-K) — 30KB
- d748780dex991.htm (EX-99.1) — 6KB
- 0001193125-24-070787.txt ( ) — 190KB
- dcth-20240318.xsd (EX-101.SCH) — 3KB
- dcth-20240318_def.xml (EX-101.DEF) — 13KB
- dcth-20240318_lab.xml (EX-101.LAB) — 21KB
- dcth-20240318_pre.xml (EX-101.PRE) — 14KB
- d748780d8k_htm.xml (XML) — 5KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated March 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DELCATH SYSTEMS, INC. Date: March 19, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer